Approval by country
Takeda is committed to supporting patients with Severe Congenital Protein C Deficiency around the globe.
CEPROTIN® [Protein C Concent rate (Human)] is FDA-approved in the United States, EMA approved in Europe, and registered in an additional 8 countries.
CEPROTIN® may not be available in all countries. Please consult your local Takeda representative.
For more information, please visit
Takeda.com